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Summary
Objective: To investigate the chondrogenic potential of growth factor-stimulated periosteal cells with respect to the activity of Hypoxia-
inducible Factor 1a (HIF-1a).
Methods: Scaffold-bound autologous periosteal cells, which had been activated by Insulin-like Growth Factor 1 (IGF-1) or Bone Morphoge-
netic Protein 2 (BMP-2) gene transfer using both adeno-associated virus (AAV) and adenoviral (Ad) vectors, were applied to chondral lesions
in the knee joints of miniature pigs. Six weeks after transplantation, the repair tissues were investigated for collagen type I and type II content
as well as for HIF-1a expression. The functional role of phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) and
mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling on BMP-2/IGF-1-induced HIF-1a expression
was assessed in vitro by employing speciﬁc inhibitors.
Results: Unstimulated periosteal cells formed a ﬁbrous extracellular matrix in the superﬁcial zone and a ﬁbrocartilaginous matrix in deep
zones of the repair tissue. This zonal difference was reﬂected by the absence of HIF-1a staining in superﬁcial areas, but moderate
HIF-1a expression in deep zones. In contrast, Ad/AAVBMP-2-stimulated periosteal cells, and to a lesser degree Ad/AAVIGF-1-infected
cells, adopted a chondrocyte-like phenotype with strong intracellular HIF-1a staining throughout all zones of the repair tissue and formed
a hyaline-like matrix. In vitro, BMP-2 and IGF-1 supplementation increased HIF-1a protein levels in periosteal cells, which was based on
posttranscriptional mechanisms rather than de novo mRNA synthesis, involving predominantly the MEK/ERK pathway.
Conclusion: This pilot experimental study on a relatively small number of animals indicated that chondrogenesis by precursor cells is facilitated
in deeper hypoxic zones of cartilage repair tissue and is stimulated by growth factors which enhance HIF-1a activity.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Chondral lesions of the joint surface have a limited
endogenous healing potential because the access of repair
cells to the lesions is restricted. Therefore, therapeutic
attempts focus on the targeted supply of a cell population
capable of producing new cartilage tissue. A number of
mesenchymal tissues have been shown to contain cells
with multilineage differentiation potential including chondro-
genesis1e5. Cells from these donor tissues are available
abundantly, can often be isolated by minimally invasive
procedures without violating the articular surface, have
a high proliferative capacity and retain their chondrogenic
potential even in advanced age6,7.
However, in vitro the differentiation of such precursor
cells into chondrocyte-like cells hardly occurs spontane-
ously. Therefore, speciﬁc biochemical and biophysical
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1457high cell densities or low oxygen levels are used to induce
chondrogenesis. Within healthy articular cartilage tissue,
chondrocytes are normally exposed to a hypoxic environ-
ment with oxygen levels as low as 1% in deep layers8,
and cell culture experiments have demonstrated that
hypoxic conditions promote chondrogenesis and the
synthesis of cartilage matrix components9,10. A central
regulator of the adaptation of cells to low oxygen levels is
the transcription factor Hypoxia-inducible Factor 1 (HIF-1),
which is responsible for a variety of cellular functions includ-
ing anaerobic energy supply, erythropoiesis, angiogenesis,
regulation of the pH and cell survival11e14. Recent studies
also suggested that its subunit HIF-1a plays an important
role in chondrogenesis, joint formation and stabilization of
the chondrocytic phenotype12,15,16.
The regulation of HIF-1 levels is complex and the activity
of this transcription factor is supposed to be predominantly
modulated by the rate of speciﬁc protein degradation of its
subunit HIF-1a rather than by stimulation of gene expres-
sion. Under physiological, normoxic conditions, oxygen-
dependent prolyl hydroxylases (PHDs) modify two proline
residues of the HIF-1a protein, which permits its recognition
by the von Hippel-Lindau protein followed by capture
through an E3-ubiquitineligase complex and subsequent
1458 K. Gelse et al.: Chondrogenic differentiation of growth factor-stimulated precursor cellsrapid proteasomal degradation14. Among at least three HIF-
speciﬁc PHDs1e3, which all might play distinct roles, PHD2
is considered as the key oxygen sensor controlling HIF-1a
levels by catalyzing its degradation17.
Here, we assessed the chondrogenic differentiation of
unstimulated and Bone Morphogenetic Protein 2 (BMP-2)-
or Insulin-like Growth Factor 1 (IGF-1)-stimulated, scaf-
fold-bound periosteal cells that were applied to a large
chondral lesion in miniature pigs. This study aimed at an
evaluation of composition, quality and zonal pattern of the
newly formed tissue with particular attention to the activity
of HIF-1a. Furthermore, the functional relationship between
IGF-1 or BMP-2 stimulation and HIF-1a activity and its
mechanisms were of interest.Materials and methodsADENOVIRAL (Ad) AND ADENO-ASSOCIATED
VIRUS (AAV) VECTORSThe Ad vectors AdBMP-2 and AdIGF-1, carrying human BMP-2 or IGF-1
cDNA, respectively, under the control of the CMV promotor, have been
described4. Viruses were propagated in 911 cells, puriﬁed by ultracentrifuga-
tion in a caesium chloride gradient and dialyzed against a storage buffer
containing 10% glycerol. The concentrations of the vector stocks, as deter-
mined by plaque assay on 911 cells, ranged from 1 1010 to 3 1010 plaque
forming units (pfu)/ml.
The AAV serotype 2-derived vectors AAVBMP-2 and AAVIGF-1 were
generated by inserting human BMP-2 or IGF-1 cDNA, respectively, under
the control of a CMV promotor into an AAV type 2 backbone. Replication-
deﬁcient viruses were produced in human embryonic kidney (HEK293) cells
by cotransfection of three plasmids as described by Xiao et al.18 and puriﬁed
according to established protocols19. The concentrations of the vector stocks
ranged from 1.5 109 to 4.0 109 infectious particles (i.p.)/ml.ISOLATION OF MESENCHYMAL CELLSSix female adult miniature pigs aged 18 months (Ellegaard, Denmark)
with body weights of 35e40 kg were used in this study.
For isolation of autologous periosteal cells, the pigs were anesthetized
and cells were obtained from the cambium layer of the periosteum of the right
tibia as described previously20. Cell culture was performed at 37C, 5% CO2,
in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supplemented with 10%
fetal calf serum (FCS), insulin-transferrin-selenium (1 ITS) (Sigma-Aldrich,
Munich, Germany), ascorbate-2-phosphate (50 mg/ml) and penicillin/strepto-
mycin (100 units/ml). The cells were passaged after reaching conﬂuence.
Characterization of the cell population included reverse transcription
polymerase chain reaction (RT-PCR) to conﬁrm a marker proﬁle indicative
of mesenchymal progenitor cells. Detection of CD13, CD34, CD45, CD90,
Sca-1 and c-kit was done using the primer pairs listed in Table I.IGF-1 AND BMP-2 GENE TRANSFERAutologous periosteal cells were transferred into 15-cm dishes and, after
reaching subconﬂuence, stimulated by BMP-2 or IGF-1 gene delivery
(1.5 107 cells/dish). The vectors AdBMP-2 and AAVBMP-2, or AdIGF-1
and AAVIGF-1, were applied at predeﬁned multiplicities of infection (MOI)
of 100 pfu/cell and 1000 i.p./cell, respectively, to the cells in 10 ml of
serum-free DMEM. Two hours after the infection, 10 ml of complete culture
medium containing 20% FCS were added. Following incubation for another
24 h, the cells were washed with phosphate-buffered saline (PBS), mobilized
using trypsin/ethylene diamine tetraacetic acid (EDTA), resuspended in
DMEM containing 10% FCS and washed twice with this medium to remove
non-internalized viral particles.IN VITRO INFECTION AND QUANTIFICATION
OF BMP-2 OR IGF-1 PRODUCTIONPeriosteal cells were infected at subconﬂuence on 24-well plates (1 105
cells per well) either with AdBMP-2 or AdIGF-1 at 100 pfu/cell, AAVBMP-2 or
AAVIGF-1 at 1000 i.p./cell or simultaneously with both the Ad and the AAV
vector carrying the same growth factor DNA. The medium was replaced
every 1e2 days and exactly 24 h before collecting the supernatant. Concen-
trations of IGF-1 and BMP-2 in cell supernatants were determined 4, 7, 14,
21 and 28 days following infection using commercially available enzyme-
linked immunosorbent assay (ELISA) kits for BMP-2 (R&D Systems,Minneapolis, MN) and for IGF-1 (Diagnostics Systems Laboratories, Web-
ster, TX), according to the manufacturers’ protocols.SCAFFOLD PREPARATIONScaffolds were prepared as described previously20. Brieﬂy, BMP-2-, IGF-
1-stimulated or untreated periosteal cells were resuspended in 30 ml of
ﬁbrinogen (Beriplast, Aventis-Behring, Marburg, Germany) and seeded in
a polyglycolic acid (PGA) matrix (Soft PGA Felt, Alpha Research, Berlin, Ger-
many). Gel formation was achieved by adding 30 ml of thrombin solution (Be-
riplast, Aventis-Behring) to both sides of the cell-loaded scaffold, which was
then incubated for another 48 h in culture medium to allow cell attachment.SURGICAL PROCEDURESThree weeks after periosteal cell isolation the animals were anesthetized
as described previously20. Following disinfection of the skin around the left
knee, the knee joint capsule was opened by a medial parapatellar incision,
and the patella was displaced laterally. A large partial-thickness defect
comprising the entire medial half of the articular surface of the patella was
created using a custom-made planing tool in which the blade exceeds the
basis by 0.6 mm. Since the thickness of miniature pig cartilage at this site
is 0.7e0.9 mm, this device prevented injuries of the subchondral bone plate,
which was conﬁrmed by a complete absence of bleeding. The lateral half of
the patella was left untreated and intact.
This cartilage defect was then treated by implantation of a cell-loaded PGA
matrix. Two animals received a PGA scaffold containing 1.5 107
unstimulated autologous periosteal cells. In a second and third experimental
groups (n¼ 2) scaffolds ﬁlled with 1.5 107 Ad/AAVIGF-1-infected or Ad/
AAVBMP-2-infected autologous periosteal cells, respectively, were applied.
Thescaffoldwasﬁxedwith twoPGApins (Resor-Pin,GeistlichBiomaterials,Wol-
husen,Switzerland)asdescribedpreviously20. Toprovideasmoothsurface, abi-
layer collagen membrane (Chondrogide; Geistlich Biomaterials, Wolhusen,
Switzerland) was attached to the PGAmatrix using a 5-0 polydioxanone suture.
Then thepatella was reduced and the stability of thegraft was tested by repeated
knee ﬂexion. Joint capsule and skin were closed with vicryl sutures. The right
knee joint, previously used for isolation of the periosteal cells, was left untreated.
After this procedure the animals were allowed to move freely in their
cages and were sacriﬁced 6 weeks later. The animal study was approved
by the appropriate Institutional and Governmental Review Boards.HISTOLOGICAL AND IMMUNOHISTOCHEMICAL ASSESSMENTThe patella was ﬁxed in 4% paraformaldehyde for at least 12 h, followed
by decalciﬁcation in 0.5-M EDTA for 3 months. The large area of the repair
tissue allowed the distinction between a proximal, an intermediate and a dis-
tal third of the patella, which were assessed separately. After standard
processing in an automated tissue-processing machine, the samples were
embedded in parafﬁn. Serial transverse 5-mm sections were cut and stained
with toluidine blue to estimate the proteoglycan content or with hematoxylin
and eosin for further histological investigation.
Immunohistochemical detection of type I and type II collagenwas performed
as described previously20. Brieﬂy, deparafﬁnized sections were pretreated with
0.2% hyaluronidase (Roche, Mannheim, Germany) in PBS for 60 min and sub-
sequently with pronase (2 mg/ml in PBS, pH 7.3; Sigma-Aldrich, Munich, Ger-
many) for 60 min at 37C. The sections were then left to react at 4C with
amonoclonalmouseanti-human type I collagen antibody (MPBiomedicals, Au-
rora, OH) diluted 1:200 or with a mouse anti-human type II collagen antibody
(MP Biomedicals) diluted 1:500, followed by incubation with a biotinylated don-
key anti-mouse secondary antibody (Dianova, Hamburg, Germany). Then
a complex of streptavidin and biotinylated alkaline phosphatase was added.
Thesectionsweredevelopedwith fast redandcounterstainedwithhematoxylin.IMMUNOFLUORESCENCESerial sections of the patella were deparafﬁnized, pretreated with 10-mM
TriseHCl (pH 10) at 95C for 5 min, followed by treatment with trypsin
(Merck, Darmstadt, Germany) in PBS (1 mg/ml) at 37C for 15 min. Unspe-
ciﬁc antibody binding was blocked with 5% bovine serum albumin in PBS.
The slides were incubated overnight at 4C with a monoclonal mouse
antibody against HIF-1a (Novus Biologicals, Littleton, CO) diluted in PBS
at a ratio of 1:500. Speciﬁc binding was visualized by incubation with Cy3-
conjugated goat anti-mouse secondary antibodies (Dianova) diluted 1:50
for 3 h. After washing with Tris buffered saline (TBS; 5 mM Tris in 0.9%
NaCl, pH 7.35) the sections were covered with a mounting medium contain-
ing 40-60-Diamidino-2-phenylindole (Vector Inc., Peterborough, UK). Control
slides were treated identically but without the Cy3-conjugated antibody.
Three independent areas per specimen were investigated under a ﬂuores-
cence microscope. The percentage of HIF-1a-positive cells per ﬁeld of
view was determined either in the superﬁcial or in the deep half of the tissue.
Table I
Primer pairs used for specific gene analysis
Gene Forward primer (50e30) Reverse primer (50e30)
CD13 CTCCTCAGCGTTCGACTACC CATCCTCCAGTTGTCCTCGT
CD34 GGCCAACGGAACAGAACTTA CGACGGTTCATCAGCAAGTA
CD45 TGACCACTTCAGCAAGCATT TGGAGCATCTTTGCACAGTC
CD90 AGAAGGTGACCAGCCTAACGG TCTGAGCACTGTGACGTTCTG
Sca-1 TATGGTTTTGTGATGTTTGTCC TAGATCCAGGGGCATTGTAG
c-Kit GATGCCTTCAAGGATTTGGA TCTGAGCACTGTGACGTTCTG
HIF-1a AGGAATTATTTAGCATGTAGACTGCTGG CATAACTGGTCAGCTGTGGTAATCC
PHD2 TCAATGGCCGGACGAAAG CATTTGGATTATCAACATGACGTACA
B2M GTCCCCCGAAGGTTCAGGT AGGTCTGACTGCTCCGCG
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BMP-2 OR IGF-1 AND INHIBITORS OF THE PI3K/mTOR
AND MEK/ERK PATHWAYPeriosteal cells (second or third passage) which had been plated at
a density of 5 105 cells/cm2 were serum-starved for 12 h, followed by
stimulation with recombinant human (rh) BMP-2 (R&D Systems, Minneapolis,
MN) or rhIGF-1 (R&D Systems), respectively, at concentrations of 20 ng/ml
or 100 ng/ml in serum-free medium for 24 h. A portion of the cells was treated
simultaneously with Rapamycin (100 nM; Calbiochem, San Diego, CA),
Wortmannin (100 nM; Calbiochem, San Diego, CA) or UO126 (10 mM; Prom-
ega, Madison, WI), respectively, for the same length of time. The experiment
was performed in triplicates with cells from three different animals.RNA ISOLATION AND RT-PCRTotal RNA was isolated from the cells with the Nucleo-Spin-RNA-II-Kit
(Clontech Laboratories, Mountain View, CA). RNA yields were calculated
by measuring the extinction at 260 nm. The reverse transcription reaction
was performed using the First Strand cDNA synthesis kit (Roche, Mannheim,
Germany). For detection of HIF-1a, PHD2 and the b2-microglobulin (B2M)
housekeeping gene, the primer pairs listed in Table I were used. Each
sample was subjected to 35 PCR cycles. PCR products were analyzed by
gel electrophoresis on a 2.5% agarose gel.IMMUNOBLOT ANALYSISPeriosteal cells from individual animals were plated in six-well plates at
a density of 5 105 cells/cm2 and stimulated with rhBMP-2 or rhIGF-1 as
described above. Nuclear and whole cell protein extracts were obtained
from cultured cells as described previously21. PHD2, HIF-1a and a-tubulin
were detected by Western immunoblot analysis using a polyclonal rabbit
anti-PHD2 antibody diluted 1:1000 (Novus, Littleton, CO), a polyclonal rabbit
anti-HIF-1a antibody diluted 1:200 (Cayman, Ann Arbor, MI) and a monoclo-
nal rat anti-a-tubulin antibody diluted 1:1000 (AbD Serotec, Du¨sseldorf,
Germany), respectively.
Nuclear extracts (50 mg/well) for the detection of HIF-1a or whole cell
extracts (50 mg/well) for the detection of PHD2 and a-tubulin were separated
on a 10% or 15% SDS-PAGE gel, respectively, and subsequently transferred
to a nitrocellulose membrane (0.2 mm). The blots were blocked with 1%
Western blocking reagent (Roche, Mannheim, Germany) overnight at 4C
and then probed with the speciﬁc antibodies for 4 h at room temperature.
After washing with Tris buffered saline (TBS)-Tween, the blots were incu-
bated with the respective secondary antibodies for 2 h. Bound antibodies
were detected using BM chemiluminescence blotting substrate (peroxidase)
(Roche, Mannheim, Germany).STATISTICAL ANALYSISData from the quantiﬁcation of HIF-1a-positive cells were analyzed using
Student’s t test. P values below 0.01 were considered to be signiﬁcant.ResultsPHENOTYPE OF THE PERICHONDRIAL CELLS USEDFig. 1. Production of BMP-2 or IGF-1 by 1 105 porcine periosteal
cells infected with AdBMP-2 or AdIGF-1 (100 pfu/cell) and/or
AAVBMP-2 or AAVIGF-1 (1000 i.p./cell), respectively. The protein
concentrations in the supernatant were determined with ELISAs.
The daily protein secretion per ml medium is shown.Basic characterization of cultured miniature pig periosteal
cells by RT-PCR revealed the expression of stem cell-
related antigens including Sca-1, CD13 and CD90, but no
expression of c-Kit, CD34 or CD45, which indicates their
mesenchymal progenitor status (data not shown).Periosteal cells infected simultaneously with AdBMP-2
and AAVBMP-2 or AdIGF-1 and AAVIGF-1 produced
BMP-2 or IGF-1, respectively, at biologically relevant levels
during the entire detection period in vitro. After 4 weeks of
culture, 1 105 cells still secreted signiﬁcant levels of
BMP-2 (13.8 1.7 ng/24 h) or IGF-1 (14.2 5.0 ng/24 h).
AdBMP-2 infection alone led to high initial transgene
expression with a rapid decline. In contrast, periosteal cells
that had been infected with AAVBMP-2 alone showed
sustained, but only low-level transgene expression (Fig. 1).HISTOLOGICAL CHARACTERIZATION OF CARTILAGE REPAIR
TISSUES AND DETECTION OF INTRACELLULAR
HIF-1a ACTIVITYThe chondrogenic potential of BMP-2- or IGF-1-stimu-
lated periosteal cells was investigated in a miniature pig
model with a large partial-thickness cartilage defect com-
prising the medial half of the articular surface of the patella.
In six miniature pigs, autologous periosteal cells were ob-
tained 3 weeks prior to surgical treatment and ﬁrst
expanded ex vivo. For two animals, a chondrogenic stimu-
lus was then provided to the cells by Ad/AAV-mediated
BMP-2 gene transfer, while cells of two other animals
were infected with Ad/AAVIGF-1, followed by seeding into
a bioresorbable scaffold and transplantation onto fresh
chondral defects (Fig. 2). In another two animals, implants
of unstimulated periosteal cells served as controls.
Six weeks after transplantation the cell-based grafts had
integrated well into the preexisting cartilage in all animals
and had resisted joint loading. Due to the thickness of the
transplanted matrix, the height of the repair tissue exceeded
Fig. 2. Experimental model. In miniature pigs, partial-thickness chondral defects comprising the entire medial half of the articular surface of the
patella were created using a custom-made planer. A cell-loaded PGA matrix was ﬁxed with resorbable pins to the underlying bone (a). The
upper part of the pin holes was milled out to allow lowering of the pin heads in plane with the surface. To create a smooth surface, an additional
collagen membrane was sutured onto the PGA matrix (b). Bar¼ 1 cm.
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some irregularities in the transitional area of the defect
border [Fig. 3(a, b, f, g, k, l)]. The proteoglycan content of
the newly formed tissue was assessed by toluidine blue
staining. Parallel sections were additionally investigated
by immunohistochemistry for type I collagen, a marker of
bone and ﬁbrous tissue, and type II collagen, a major and
speciﬁc component of hyaline cartilage. Transplantation of
unstimulated periosteal cells failed to generate hyaline
cartilage [Figs. 3(aee) and 4(b)]. The superﬁcial half of
the repair tissue showed virtually no proteoglycan and
type II collagen staining and appeared to consist only of
ﬁbrous tissue. This notion was supported by the typical
spindle-cell phenotype in the superﬁcial and intermediate
layers [Fig. 4(b)]. Deeper layers showed at best the forma-
tion of ﬁbrocartilage, in which the cells partially adopted
a round phenotype and formed a matrix with faint proteogly-
can staining and partial type II collagen staining only in the
deepest zone adjacent to the preexisting underlying carti-
lage. HIF-1a immunostaining was absent in almost all cells
of the superﬁcial half of the tissue, whereas approximately
40% of the cells in the deep zones of the tissue showed
faint HIF-1a staining [Fig. 4(b), Table II].
The transplantation of Ad/AAVIGF-1-stimulated cells also
failed to produce homogeneous hyaline repair tissue. Similar
to the tissue formed by unstimulated cells, a ﬁbrous superﬁ-
cial zone lacking type II collagen could be distinguished
from ﬁbrocartilaginous deeper zones. Only the latter were
characterized byweak tomoderate pericellular accumulation
of proteoglycans and by a type II collagen-positive matrix
[Fig. 3(fej)]. Compared with the transplantation of unstimu-
lated cells, there was an increase in cellularity both in the
superﬁcial and the deep zones, however, the morphological
features of Ad/AAV-stimulated cells still differed from those of
typical chondrocytes [Fig. 4(c)].
In contrast, repair tissue formed by Ad/AAVBMP-2-stimu-
lated cells showed an intense staining for type II collagen
throughout all layers with strong toluidine blue staining
indicating a proteoglycan-rich matrix [Fig. 3(keo)]. Most
cells had adopted a chondrocyte-like round phenotype,
but did not show the typical columnar distribution as
observed in healthy articular cartilage. Occasionally, rem-
nants of the PGA matrix were still detectable in the densematrix. Interestingly, Ad/AAVBMP-2-stimulated cells were
characterized by strong HIF-1a expression throughout the
thickness of the cartilaginous repair tissue, and even in
the superﬁcial zone intracellular HIF-1a staining was clearly
detectable in more than half of the cells [Fig. 4(d), Table II].
Articular cartilage from healthy, untreated joints served as
an internal control. Here, the arrangement of the cells was
zone-speciﬁc with a horizontal pattern in the most superﬁ-
cial layer and a perpendicular pattern in deep zones. Almost
all chondrocytes in the deep zones displayed strong intra-
cellular HIF-1a immunostaining with a continuous decrease
toward the surface [Fig. 4(a), Table II].
In all samples analyzed, the underlying bone showed
strong type I collagen staining and served as additional
internal staining control. Type II collagen was always clearly
detectable in intact hyaline cartilage and calciﬁed cartilage.INDUCTION OF HIF-1a EXPRESSION BY RECOMBINANT BMP-2
AND IGF-1 ISBASEDONPOSTTRANSCRIPTIONALMECHANISMS
MEDIATED PREDOMINANTLY BY MEK/ERK SIGNALINGTo investigate the mechanisms leading to elevated HIF-
1a levels in vivo, periosteal cells were cultured in mono-
layers and exposed to rhBMP-2 or rhIGF-1 at concentrations
of 20 or 100 ng/ml for 24 h. Under 21% oxygen, even the
lower dose of rhBMP-2 (20 ng/ml) resulted in a distinct
increase of intranuclear HIF-1a levels [Fig. 5(a)]. Stimulation
with rhIGF-1 also yielded elevated HIF-1a levels. This effect
was dose-dependent, and a distinct increase was only
apparent at higher concentrations of IGF-1 (100 ng/ml).
Thus, BMP-2 was more potent in this respect. In vivo,
however, cells modiﬁed by Ad/AAV-mediated gene transfer
may provide growth factor levels in the range of up to 10 ng/
ml for at least 4 weeks (Fig. 1), but may not provide the high
concentration (100 ng/ml) used in the stimulation experi-
ments in vitro. As a positive control, periosteal cells cultured
under 1% oxygen showed high intranuclear HIF-1a levels
[Fig. 5(a)].
The next step was to investigate the mechanisms by
which growth factors such as BMP-2 and IGF-1 lead to
increased HIF-1a levels. The transcription factor HIF-1a is
strongly regulated by the rate of speciﬁc protein degrada-
tion, and an important step in this rapid process is the
Fig. 3. Periosteal cell-based resurfacing of large cartilage lesions in miniature pigs. The cartilage defects were treated by implantation of
a PGA matrix loaded with autologous periosteal cells. The resulting repair tissues were examined 6 weeks after cell transplantation by tolu-
idine blue staining (aec, feh, kem). In all six animals, the thickness of the repair tissue exceeded that of adjacent cartilage and showed some
irregularities in the transitional area of the defect border (arrowheads in a, b, f, g, k, l). The repair tissue merged well with the underlying
cartilage of the chondral lesions (arrows in c, h, m). Representative parallel sections were additionally evaluated by immunohistochemistry
for type I and type II collagens. The underlying bone showed strong type I collagen staining (c, f, i) and served as internal control. Type II
collagen was always clearly detectable in intact hyaline articular cartilage and calciﬁed cartilage (b, e, h). Unstimulated cells formed ﬁbrous
repair tissue in superﬁcial and middle zones which were positive for type I collagen (c), but negative for type II collagen (b). Only the deepest
zone consisted of ﬁbrocartilaginous tissue partially positive for type II collagen (b). Transplantation of Ad/AAVIGF-1-stimulated cells resulted in
a ﬁbrous superﬁcial zone with strong staining for type I collagen (d, f), that could be distinguished from ﬁbrocartilaginous deeper zones with
moderate pericellular accumulation of proteoglycans and a type II collagen-positive matrix (d, e). In contrast, the repair tissue produced by Ad/
AAVBMP-2-infected cells showed strong proteoglycan and type II collagen staining throughout all layers (g, h, i). Bar¼ 200 mm in cee, hej,
meo; Bar¼ 400 mm in a, b, f, g, k, l.
1461Osteoarthritis and Cartilage Vol. 16, No. 12hydroxylation of HIF-1a at certain proline residues which is
predominantly catalyzed by the oxygen-dependent hydrox-
ylase PHD2. Neither rhBMP-2 nor rhIGF-1 had detectable
inﬂuence on the intracellular level of PHD2 protein
[Fig. 5(a)] or the expression of the PHD2 gene [Fig. 5(b)].
Cultivation under 1% oxygen had no effect on PHD2 protein
or mRNA levels either [Fig. 5(a) and (b)]. Expression of
HIF-1a was neither inﬂuenced by stimulation with IGF-1 or
BMP-2 nor by hypoxia [Fig. 5(b)].
To investigate further the functional relationship between
the growth factors and HIF-1a, we exposed IGF-1- and
BMP-2-stimulated cells to inhibitors of the PI3K/mTOR or
the MEK/ERK pathway. Application of Wortmannin or
Rapamycin, inhibiting PI3K or mTOR, respectively, onlymoderately decreased the HIF-1a levels following BMP-2
and IGF-1 stimulation. However, treatment with the MEK
inhibitor UO126 nearly completely abolished HIF-1a induc-
tion by either growth factor [Fig. 5(c)], indicating that this
induction is based on posttranscriptional mechanisms medi-
ated predominantly by MEK/ERK signaling.Discussion
Biopsies of cartilage repair tissues resulting from micro-
fracturing or autologous chondrocyte implantation often
reveal zone-speciﬁc cellular differentiation patterns which
are characterized by a superﬁcial ﬁbrous layer and areas
Fig. 4. Zonal differences in cellular morphology and HIF-1a immunostaining (red). Healthy cartilage is characterized by a homogeneous
proteoglycan-rich matrix and strong intracellular HIF-1a levels particularly in the deep zones (a). Unstimulated periosteal cells adopted
predominantly a spindle-cell like phenotype with no HIF-1a staining in the superﬁcial zone and partial staining in the deepest layer (b). Tissue
generated by Ad/AAVIGF-1-stimulated cells was characterized by high cellularity. Only the cells in the deep zones which were surrounded by
a proteoglycan-rich pericellular matrix showed HIF-1a staining, while the superﬁcial ﬁbroblast-like cells were negative (c). Ad/AAVBMP-2-stim-
ulated cells adopted a round chondrocyte-like phenotype throughout all layers with mostly strong HIF-1a signals (d). Bar¼ 50 mm.
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have conﬁrmed this tendency. The oxygen distribution pat-
tern may help to explain this phenomenon, since particularly
the deepest zones are assumed to be exposed to more
hypoxic conditions, provided that the subchondral bone
plate remains intact or has been reconstituted. Numerous
in vitro-studies have shown that low partial pressures of
oxygen are involved in promoting the chondrogenic differ-
entiation process9,10,12,24. A recent study on full-thickness
cartilage defects in miniature pigs also demonstrated thebeneﬁcial effect of a functional barrier toward the vascular-
ized bone marrow by using an anti-angiogenic substance25.
One of the most important factors associated with low
oxygen tensions is the transcription factor HIF-1. Although
HIF-1 is known to have multiple functions in many tissues,
its role in the avascular cartilage and in embryonal mesen-
chymal condensations is of great importance. HIF-1 was
shown to transactivate Sox9, a key factor for the expression
of numerous cartilage-speciﬁc genes, in mesenchymal
cells12. A recent study demonstrated direct binding of the
Table II
Percentage of HIF-1a-positive cells in the superficial half and the
deep half of the respective repair tissues and healthy articular
cartilage. Three independent superficial and deep areas per
specimen were investigated. *P < 0.05, ***P < 0.001 (versus
unstimulated repair tissue)
Tissue Zone % of HIF-1a-
positive cells
Healthy articular cartilage Superﬁcial 4.9 (3.9)
Deep 92.8* (6.0)
Unstimulated repair tissue Superﬁcial 0.8 (0.3)
Deep 42.0 ( 7.5)
Ad/AAVIGF-1-stimulated
repair tissue
Superﬁcial 3.1* (1.2)
Deep 55.9 (9.0)
Ad/AAVBMP-2-stimulated
repair tissue
Superﬁcial 53.2*** (8.2)
Deep 74.5* (9.0)
1463Osteoarthritis and Cartilage Vol. 16, No. 12HIF-1 subunit HIF-1a to the Sox9 promotor region26. Further-
more, targeted deletion of HIF-1a in stromal or prechondro-
genic cells speciﬁcally compromised chondrogenesis while
osteogenesis and adipogenesis were not affected16,26.
Our study is the ﬁrst to show in vivo that the expression of
HIF-1a correlates with the quality of a cartilage repair tissue.
Furthermore, we could demonstrate that the beneﬁcial
effects of BMP-2 on inducing chondrogenesis in the repair
tissue were associated with increased HIF-1a expression.Fig. 5. (a) Induction of HIF-1a by administration of BMP-2 or IGF-1 or c
increasing concentrations of BMP-2 or IGF-1. Nuclear protein extracts wer
for PHD2 protein detection by Western blotting. Blots were stripped and re
on the expression of HIF-1a and PHD2. Total RNA extracts from stimula
expression. Detection of B2M expression served as an internal control. (c)
decreased by Wortmannin (PI3K inhibitor) and Rapamycin (mTOR inhibi
blots and gels are representative resultsIn our experiments in vitro using periosteal cells, HIF-1a
protein levels could also be increased by stimulation with
IGF-1,which conﬁrms thedata fromprevious studies onother
cell types including retinal pigment epithelial cells and colon
cancer cells27,28. Theminor effects of IGF-1 on HIF-1a levels
in the repair tissue of our in vivo-model may be explained by
adose-dependence thatwasalsoobserved in vitro. Thus, the
IGF-1 quantities provided by gene transfer and subsequent
cell transplantation in vivo did presumably not reach the
levels that were shown to be required in vitro. Consequently,
IGF-1 may have a lower potency on increasing intracellular
HIF-1a levels compared with BMP-2.
Another aim of this study was to investigate the mecha-
nisms by which growth- or differentiation factors such as
IGF-1 or BMP-2 may lead to an increase of HIF-1a expres-
sion. In principal, increased protein levels can be achieved
via enhanced gene expression or translation or by stabiliza-
tion of mRNA or protein by inhibition of their degradation. In
our experiments, neither BMP-2 nor IGF-1 had a direct
inﬂuence on HIF-1a gene expression. This conﬁrms recent
observations made on other cell types, in which IGF-1 had
no effect on HIF-1a mRNA synthesis either27,28.
Probably the most important pathway regulating HIF-1 is
the modulation of degradation of its HIFa subunits, which is
predominantly mediated by the oxygen-dependent PHD2.
However, in our experiments in vitro, neither IGF-1 norell cultivation under hypoxia. Periosteal cells were stimulated with
e analyzed for HIF-1a protein, and whole cell lysates were collected
-probed for a-tubulin. (b) BMP-2, IGF-1 and hypoxia have no effect
ted cells were investigated by RT-PCR for HIF-1a and PHD2 gene
HIF-1a induction by BMP-2 or IGF-1 administration was moderately
tor), but nearly completely abolished by UO126 (MEK inhibitor). All
of three independent experiments.
Fig. 6. Proposed functional relationship between different chondro-
genic growth- or differentiation factors and HIF-1a, which was
recently shown to transactivate Sox9, a key transcription factor
for a number of cartilage-speciﬁc genes. BMP-2 signaling does
not only involve the Smad1/5/8 cascade, but similar to IGF-1 also
the PI3K/mTOR and the MEK/ERK pathway. Particularly UO126,
a MEK inhibitor, nearly completely abolished HIF-1a induction by
BMP-2 or IGF-1. Inhibition of PI3K by Wortmannin and inhibition
of mTOR by Rapamycin affected the HIF-1a levels only moder-
ately. Neither IGF-1 nor BMP-2 had any effect on the HIF-1a or
PHD2 gene expression. This stands in contrast to the effects of
TGFb which was shown to inhibit PHD2 gene expression via
Smad2/3.
1464 K. Gelse et al.: Chondrogenic differentiation of growth factor-stimulated precursor cellsBMP-2 interferredwith the gene expression or protein level of
PHD2. Thus the effects of IGF-1 andBMP-2 are unlikely to be
mediated by an inﬂuence on the stability of theHIF-1a protein
either. As far as IGF-1 is concerned, these observations have
already been conﬁrmed in studies on other cell types. Those
studies suggested that IGF-1 increasesHIF-1a protein levels
through a posttranscriptional mechanism involving the PI3K/
mTOR and the MEK/ERK pathways without modulating HIF-
1a transcription but by stimulation of its translation27,28,29.We
could conﬁrm this effect also for periosteal cells. The increase
of HIF-1a levels subsequent to an IGF-1 stimulus ismediated
predominantly via the MEK/ERK pathway and to a lesser
extent via the PI3K/mTOR pathway.
To date, no data on interactive mechanisms between
BMP-2 and increased HIF-1a levels have been published.
In fact, it has been shown that the functionally related trans-
forming growth factor-b (TGFb) stabilizes HIF-1a protein by
inhibiting the expression of PHD2 and thus inhibiting HIF-1a
degradation via a cascade involving Smad2/3 signaling30.
However, in our experiments, BMP-2 had no inﬂuence on
the expression of PHD2 or PHD3 (K. Gelse, unpublished
data). This may be based on the fact that, in contrast to
TGFb signaling, BMP-2 involves the Smad1/5/8 cascade
rather than the Smad2/3 cascade31, which may explain
the different effects of TGFb and BMP-2 on PHD2
expression.
There is good evidence that, intracellulary, BMP signals
are not only transduced by the Smad pathway but also by
the PI3K/mTOR and mitogen-activated protein (MAP)-
kinase cascades32,33. In this study, the inhibiton of MEK
by UO126 almost completely abolished HIF-1a induction
following BMP-2 stimulation, indicating that the MEK/ERK
pathway plays an important role in increasing the levels ofHIF-1a. The inhibiton of PI3K and mTOR by Wortmannin
or Rapamycin, respectively, had only a moderate effect. Fu-
ture studies will have to investigate the role of the Smad1/5/
8 signaling in this respect.
As the conclusions of this study are weakened by the
relatively small number of animals, further work on larger
groups of animals is required, including the additional use
of other cells types such as committed chondrocytes. Nev-
ertheless, the data of this pilot experimental work contribute
new aspects to the knowledge about pro-chondrogenic
signaling pathways as summarized in Fig. 6, supporting
the conclusion that growth factors of different families may
use common as well as distinct pathways to exert their stim-
ulatory effects on chondrogenesis.
In many experimental studies, chondroinductive differen-
tiation factors such as BMPs have been shown to stimulate
efﬁciently the formation of hyaline-like repair tissue. How-
ever, the clinical use of such factors may be limited by tre-
mendous costs arising from the administration of
recombinant proteins, and gene transfer approaches may
be hindered because of safety concerns. Therefore, the as-
sociation of HIF-1a with chondrogenic pathways may be
particularly interesting. Although, the interactions between
hypoxia, HIF-1a and chondrogenic pathways will have to
be explored in detail in future, our ﬁndings may encourage
the establishment of new cartilage repair strategies that in-
corporate the potential beneﬁcial role of low oxygen and/or
elevated HIF-1a levels as a therapeutic tool for cartilage
repair.
Conﬂict of interest
All authors disclose any ﬁnancial and personal relationships
with other people or organizations that could inappropriately
inﬂuence (bias) this work, including employment, consultan-
cies, stock ownership, honoraria, paid expert testimony,
patent applications/registrations, and grants or other funding.Acknowledgements
WethankE.Koppmann,M.Geßlein andH.Rohrmu¨ller for ex-
cellent technical assistance, Dr Philippe Moullier (Genethon,
Nantes, France) for providing the plasmid pRepCap,
Dr Richard Samulski (University of North Carolina, USA) for
the plasmid pXX6-80, and Geistlich Biomaterials (Wolhusen,
Switzerland) for the Chondrogide membranes. Supported by
the Interdisciplinary Center of Clinical Research (IZKF) at the
University Hospital Erlangen (grants C1 and C7) and the
German Research Foundation (grant GE 1975/1-2).Supplementary data
Supplementary material associated with this article can
be found, in the online version, at doi:10.1016/j.joca.2008.
04.006.References
1. Winter A, Breit S, Parsch D, Benz K, Steck E, Hauner H, et al. Cartilage-
like gene expression in differentiated human stem cell spheroids:
a comparison of bone marrow-derived and adipose tissue-derived
stromal cells. Arthritis Rheum 2003;48:418e29.
2. Park J, Gelse K, Frank S, von der Mark K, Aigner T, Schneider H.
Transgene-activated mesenchymal cells for articular cartilage repair:
a comparison of primary bone marrow-, perichondrium/periosteum-
and fat-derived cells. J Gene Med 2006;8:112e25.
1465Osteoarthritis and Cartilage Vol. 16, No. 123. De Bari C, Dell’Accio F, Tylzanowski P, Luyten FP. Multipotent
mesenchymal stem cells from adult human synovial membrane.
Arthritis Rheum 2001;44:1928e42.
4. Gelse K, Jiang QJ, Aigner T, Ritter T, Wagner K, Poschl E, et al.
Fibroblast-mediated delivery of growth factor complementary DNA
into mouse joints induces chondrogenesis but avoids the disadvan-
tages of direct viral gene transfer. Arthritis Rheum 2001;44:1943e53.
5. Adachi N, Sato K, Usas A, Fu FH, Ochi M, Han CW, et al. Muscle
derived, cell based ex vivo gene therapy for treatment of full thickness
articular cartilage defects. J Rheumatol 2002;29:1920e30.
6. De Bari C, Dell’Accio F, Luyten FP. Human periosteum-derived cells
maintain phenotypic stability and chondrogenic potential throughout
expansion regardless of donor age. Arthritis Rheum 2001;44:85e95.
7. DeBariC,Dell’AccioF,VanlauweJ,EyckmansJ,Khan IM,ArcherCW,etal.
Mesenchymalmultipotency of adult human periosteal cells demonstrated
by single-cell lineage analysis. Arthritis Rheum 2006;54:1209e21.
8. Silver IA. Measurement of pH and ionic composition of pericellular sites.
Philos Trans R Soc Lond B Biol Sci 1975;271:261e72.
9. Hirao M, Tamai N, Tsumaki N, Yoshikawa H, Myoui A. Oxygen tension
regulates chondrocyte differentiation and function during endochon-
dral ossiﬁcation. J Biol Chem 2006;281:31079e92.
10. Kurz B, Domm C, Jin M, Sellckau R, Schunke M. Tissue engineering of
articular cartilage under the inﬂuence of collagen I/III membranes and
low oxygen tension. Tissue Eng 2004;10:1277e86.
11. Pfander D, Cramer T, Schipani E, Johnson RS. HIF-1alpha controls
extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci
2003;116:1819e26.
12. Robins JC, Akeno N, Mukherjee A, Dalal RR, Aronow BJ, Koopman P,
et al. Hypoxia induces chondrocyte-speciﬁc gene expression in
mesenchymal cells in association with transcriptional activation of
Sox9. Bone 2005;37:313e22.
13. Schipani E, Ryan HE, Didrickson S, Kobayashi T, Knight M,
Johnson RS. Hypoxia in cartilage: HIF-1alpha is essential for chon-
drocyte growth arrest and survival. Genes Dev 2001;15:2865e76.
14. Maxwell PH, Ratcliffe PJ. Oxygen sensors and angiogenesis. Semin
Cell Dev Biol 2002;13:29e37.
15. Provot S, Zinyk D, Gunes Y, Kathri R, Le Q, Kronenberg HM, et al. Hif-
1alpha regulates differentiation of limb bud mesenchyme and joint
development. J Cell Biol 2007;177:451e64.
16. Malladi P, Xu Y, Chiou M, Giaccia AJ, Longaker MT. Hypoxia inducible
factor-1alpha deﬁciency affects chondrogenesis of adipose-derived
adult stromal cells. Tissue Eng 2007;13:1159e71.
17. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. HIF
prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state
levels of HIF-1alpha in normoxia. EMBO J 2003;22:4082e90.
18. Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-
associated virus vectors in the absence of helper adenovirus. J Virol
1998;72:2224e32.
19. Snyder RO, Xiao X, Samulski RJ. Production of recombinant adeno-
associated viral vectors. In: Dracpoli N, Haines J, Krof B, Eds.
Current Protocols in Human Genetics. New York: Wiley; 1996:
1e24.20. Gelse K, Muhle C, Franke O, Park J, Jehle M, Durst K, et al. Cell-based
resurfacing of large cartilage defects: long-term evaluation of grafts
from autologous transgene-activated periosteal cells in a porcine
model of osteoarthritis. Arthritis Rheum 2008;58:475e88.
21. Grimmer C, Pfander D, Swoboda B, Aigner T, Mueller L, Hennig FF,
et al. Hypoxia-inducible factor 1alpha is involved in the prostaglandin
metabolism of osteoarthritic cartilage through up-regulation of micro-
somal prostaglandin E synthase 1 in articular chondrocytes. Arthritis
Rheum 2007;56:4084e94.
22. Behrens P, Bitter T, Kurz B, Russlies M. Matrix-associated autologous
chondrocyte transplantation/implantation (MACT/MACI) e 5-year
follow-up. Knee 2006;13:194e202.
23. Knutsen G, Engebretsen L, Ludvigsen TC, Drogset JO, Grontvedt T,
Solheim E, et al. Autologous chondrocyte implantation compared
with microfracture in the knee. A randomized trial. J Bone Joint
Surg Am 2004;86-A:455e64.
24. Chen L, Fink T, Ebbesen P, Zachar V. Temporal transcriptome of mouse
ATDC5 chondroprogenitors differentiating under hypoxic conditions.
Exp Cell Res 2006;312:1727e44.
25. Hunziker EB, Driesang IM. Functional barrier principle for growth-factor-
based articular cartilage repair. Osteoarthritis Cartilage 2003;11:
320e7.
26. Amarilio R, Viukov SV, Sharir A, Eshkar-Oren I, Johnson RS, Zelzer E.
HIF1{alpha} regulation of Sox9 is necessary to maintain differentiation
of hypoxic prechondrogenic cells during early skeletogenesis.
Development 2007;134:3917e28.
27. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL. Insulin-like
growth factor 1 induces hypoxia-inducible factor 1-mediated vascular
endothelial growth factor expression, which is dependent on MAP
kinase and phosphatidylinositol 3-kinase signaling in colon cancer
cells. J Biol Chem 2002;277:38205e11.
28. Treins C, Giorgetti-Peraldi S, Murdaca J, Monthouel-Kartmann MN, Van
Obberghen E. Regulation of hypoxia-inducible factor (HIF)-1 activity
and expression of HIF hydroxylases in response to insulin-like growth
factor I. Mol Endocrinol 2005;19:1304e17.
29. Catrina SB, Botusan IR, Rantanen A, Catrina AI, Pyakurel P, Savu O,
et al. Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-
2alpha are expressed in kaposi sarcoma and modulated by insulin-
like growth factor-I. Clin Cancer Res 2006;12:4506e14.
30. McMahon S, Charbonneau M, Grandmont S, Richard DE, Dubois CM.
Transforming growth factor beta1 induces hypoxia-inducible factor-1
stabilization through selective inhibition of PHD2 expression. J Biol
Chem 2006;281:24171e81.
31. Wan M, Cao X. BMP signaling in skeletal development. Biochem
Biophys Res Commun 2005;328:651e7.
32. Langenfeld EM, Kong Y, Langenfeld J. Bone morphogenetic protein-2-
induced transformation involves the activation of mammalian target
of rapamycin. Mol Cancer Res 2005;3:679e84.
33. Zhao M, Xiao G, Berry JE, Franceschi RT, Reddi A, Somerman MJ.
Bone morphogenetic protein 2 induces dental follicle cells to
differentiate toward a cementoblast/osteoblast phenotype. J Bone
Miner Res 2002;17:1441e51.
